España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
abrdn Life Sciences
HQL
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$13.85
0.05
0.36%
At close: -
$14.35
0.50
3.61%
After Hours: Feb 20, 5:18 PM EDT
Get Report
Comment
abrdn Life Sciences (HQL) Forecast
News
Earnings
abrdn Life Sciences (HQL) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for abrdn Life Sciences (NYSE:HQL) Stock
abrdn Life Sciences Stock (NYSE: HQL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, April 30, 2024
Around $1.5M Bet On Abrdn Life Sciences Investors? Check Out These 3 Stocks Insiders Are Buying
Avi Kapoor
Friday, December 29, 2023
Saba Capital Management, Reported A 5.31% Stake In abrdn Life Sciences; Saba Acquired The Shares Because They Believe That The Common Shares Are Undervalued And Represent An Attractive Investment Opportunity
Charles Gross
Thursday, September 21, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Wednesday, September 06, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Monday, August 21, 2023
Wednesday Is Your Last Chance To Buy Tekla Life Sciences Invts Before The Dividend Payout
Benzinga Insights
Friday, November 18, 2022
Tekla Life Sciences: Dividend Insights
Benzinga Insights
Monday, August 22, 2022
Tekla Life Sciences: Dividend Insights
Benzinga Insights
Monday, June 13, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, June 10, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Monday, May 23, 2022
Tekla Life Sciences's Ex-Dividend Date Is Thursday, Here's What You Need To Know
Benzinga Insights
Friday, February 19, 2021
Stocks That Hit 52-Week Highs On Friday
Benzinga Insights
Tuesday, February 16, 2021
Tekla Life Sciences Increases Dividend From $...
Benzinga Newsdesk
Wednesday, February 10, 2021
Stocks That Hit 52-Week Highs On Wednesday
Benzinga Insights
Tuesday, February 09, 2021
Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights
Monday, February 08, 2021
Stocks That Hit 52-Week Highs On Monday
Benzinga Insights
Thursday, January 21, 2021
Stocks That Hit 52-Week Highs On Thursday
Benzinga Insights
Wednesday, January 20, 2021
Stocks That Hit 52-Week Highs On Wednesday
Benzinga Insights
Tuesday, January 19, 2021
Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights
Monday, December 28, 2020
Stocks That Hit 52-Week Highs On Monday
Benzinga Insights
Thursday, December 24, 2020
Stocks That Hit 52-Week Highs On Thursday
Benzinga Insights
Wednesday, December 23, 2020
Stocks That Hit 52-Week Highs On Wednesday
Benzinga Insights
Tuesday, December 22, 2020
Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights
Friday, December 18, 2020
Stocks That Hit 52-Week Highs On Friday
Benzinga Insights
Thursday, December 17, 2020
Stocks That Hit 52-Week Highs On Thursday
Benzinga Insights
Wednesday, December 16, 2020
Stocks That Hit 52-Week Highs On Wednesday
Benzinga Insights
Monday, December 14, 2020
Stocks That Hit 52-Week Highs On Monday
Benzinga Insights
Tuesday, November 24, 2020
Understanding Tekla Life Sciences's Ex-Dividend Date
Benzinga Insights
Friday, July 17, 2020
Stocks That Hit 52-Week Highs On Friday
Benzinga Insights
Wednesday, July 15, 2020
Stocks That Hit 52-Week Highs On Wednesday
Benzinga Insights
Monday, July 06, 2020
Stocks That Hit 52-Week Highs On Monday
Benzinga Insights
Tuesday, June 23, 2020
Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights
Monday, March 16, 2020
Stocks That Hit 52-Week Lows On Monday
Lisa Levin
Thursday, March 12, 2020
Stocks That Hit 52-Week Lows On Thursday
Lisa Levin
Thursday, March 21, 2019
Tekla Healthcare Investors, Tekla Life Scienc...
Benzinga Newsdesk
Monday, December 17, 2018
Stocks Which Set New 52-Week Low Last Trading...
Benzinga Newsdesk
Monday, December 10, 2018
Stocks Which Set New 52-Week Low The Last Tra...
Benzinga Newsdesk
Wednesday, November 21, 2018
Stocks Which Set New 52-Week Low Yesterday, T...
Benzinga Newsdesk
Tuesday, October 30, 2018
Stocks Which Set New 52-Week Low Yesterday, O...
Benzinga Newsdesk
Monday, October 29, 2018
Stocks Which Set New 52-Week Low Friday, Octo...
Benzinga Newsdesk
Thursday, April 14, 2016
Tekla Life Sciences Investors Declares $0.37 Stock Distribution A Share
Benzinga
Thursday, March 24, 2016
Tekla Life Science Renews Buyback FOr Up To 1...
Benzinga
Thursday, March 19, 2015
Tekla Life Sciences Investors Announce Renewa...
Benzinga
Thursday, October 23, 2014
CardioKinetix Initiates Study in China of Fir...
Benzinga
Monday, May 19, 2014
H&Q Announces Terms of Rights Offering: Curre...
Benzinga
Friday, November 15, 2013
H&Q Life Sciences Investors Declares Stock Distribution of $0.40/Share
Benzinga
Wednesday, June 06, 2012
Three Keys to Finding Good Dividend Stocks
Benzinga
Friday, March 23, 2012
H&Q Life Sciences Investors Announces Renewal of Share Repurchase Program; Up to 12%
Benzinga
Thursday, June 30, 2011
H&Q Life Sciences Investors Announces Share Repurchase Program for 12% of Common Stock
Benzinga
Thursday, June 02, 2011
H&Q Life Sciences Investors Announces Final Results of Tender Offer
Benzinga
Wednesday, June 01, 2011
H&Q Life Sciences Investors Announces Preliminary Results of Tender Offer
Benzinga
Show More
